BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 9371520)

  • 41. Distinct p53-mediated G1/S checkpoint responses in two NIH3T3 subclone cells following treatment with DNA-damaging agents.
    Huang TS; Kuo ML; Shew JY; Chou YW; Yang WK
    Oncogene; 1996 Aug; 13(3):625-32. PubMed ID: 8760304
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells.
    Goldwasser F; Shimizu T; Jackman J; Hoki Y; O'Connor PM; Kohn KW; Pommier Y
    Cancer Res; 1996 Oct; 56(19):4430-7. PubMed ID: 8813137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The G2/M DNA damage checkpoint inhibits mitosis through Tyr15 phosphorylation of p34cdc2 in Aspergillus nidulans.
    Ye XS; Fincher RR; Tang A; Osmani SA
    EMBO J; 1997 Jan; 16(1):182-92. PubMed ID: 9009279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage.
    Tsvetkov L; Stern DF
    Cell Cycle; 2005 Jan; 4(1):166-71. PubMed ID: 15611664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential contribution of inhibitory phosphorylation of CDC2 and CDK2 for unperturbed cell cycle control and DNA integrity checkpoints.
    Chow JP; Siu WY; Ho HT; Ma KH; Ho CC; Poon RY
    J Biol Chem; 2003 Oct; 278(42):40815-28. PubMed ID: 12912980
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage.
    Jin P; Hardy S; Morgan DO
    J Cell Biol; 1998 May; 141(4):875-85. PubMed ID: 9585407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression.
    Ryu MS; Lee MS; Hong JW; Hahn TR; Moon E; Lim IK
    Exp Cell Res; 2004 Sep; 299(1):159-70. PubMed ID: 15302583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A brief staurosporine treatment of mitotic cells triggers premature exit from mitosis and polyploid cell formation.
    Hall LL; Th'ng JP; Guo XW; Teplitz RL; Bradbury EM
    Cancer Res; 1996 Aug; 56(15):3551-9. PubMed ID: 8758926
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines.
    Nishio K; Ishida T; Arioka H; Kurokawa H; Fukuoka K; Nomoto T; Fukumoto H; Yokote H; Saijo N
    Anticancer Res; 1996; 16(6B):3387-95. PubMed ID: 9042196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transient failure to dephosphorylate the cdc2-cyclin B1 complex accompanies radiation-induced G2-phase arrest in HeLa cells.
    Metting NF; Little JB
    Radiat Res; 1995 Sep; 143(3):286-92. PubMed ID: 7652166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Caffeine induces TP53-independent G(1)-phase arrest and apoptosis in human lung tumor cells in a dose-dependent manner.
    Qi W; Qiao D; Martinez JD
    Radiat Res; 2002 Feb; 157(2):166-74. PubMed ID: 11835680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanism of ultraviolet B-induced cell cycle arrest in G2/M phase in immortalized skin keratinocytes with defective p53.
    Athar M; Kim AL; Ahmad N; Mukhtar H; Gautier J; Bickers DR
    Biochem Biophys Res Commun; 2000 Oct; 277(1):107-11. PubMed ID: 11027648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of Cdc2/cyclin B activation in Xenopus egg extracts via inhibitory phosphorylation of Cdc25C phosphatase by Ca(2+)/calmodulin-dependent protein [corrected] kinase II.
    Hutchins JR; Dikovskaya D; Clarke PR
    Mol Biol Cell; 2003 Oct; 14(10):4003-14. PubMed ID: 14517314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of cisplatin-induced ATR activity and enhanced sensitivity to cisplatin.
    Yazlovitskaya EM; Persons DL
    Anticancer Res; 2003; 23(3B):2275-9. PubMed ID: 12894503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. G1 versus G2 cell cycle arrest after adriamycin-induced damage in mouse Swiss3T3 cells.
    Siu WY; Yam CH; Poon RY
    FEBS Lett; 1999 Nov; 461(3):299-305. PubMed ID: 10567715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of p34CDC28 tyrosine phosphorylation is not required for entry into mitosis in S. cerevisiae.
    Amon A; Surana U; Muroff I; Nasmyth K
    Nature; 1992 Jan; 355(6358):368-71. PubMed ID: 1731251
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell cycle regulation of the p34cdc2 inhibitory kinases.
    Atherton-Fessler S; Liu F; Gabrielli B; Lee MS; Peng CY; Piwnica-Worms H
    Mol Biol Cell; 1994 Sep; 5(9):989-1001. PubMed ID: 7841526
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of wee1 and its related cell cycle components in mouse early stage follicles.
    Park CE; Kim YH; Jeon EH; Cha KY; Lee SH; Lee KA
    Cells Tissues Organs; 2004; 177(4):221-8. PubMed ID: 15459478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bleomycin-induced over-replication involves sustained inhibition of mitotic entry through the ATM/ATR pathway.
    Nakayama Y; Igarashi A; Kikuchi I; Obata Y; Fukumoto Y; Yamaguchi N
    Exp Cell Res; 2009 Sep; 315(15):2515-28. PubMed ID: 19527713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.
    Wang Q; Fan S; Eastman A; Worland PJ; Sausville EA; O'Connor PM
    J Natl Cancer Inst; 1996 Jul; 88(14):956-65. PubMed ID: 8667426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.